Stock Report

All about this stock under one free report Last Updated: 10-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Kalvista Pharmaceuticals Inc (KALV) Key Ratios

Stock Card factsheet share-fund-plan-icon

$27.00

$0.00 (0.00%)

As on 12-Jun-2026 09:30EDT

Market cap

info icon

$1,438 Mln

Revenue (TTM)

info icon

$143 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

49

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 46.65 -- -- -- 54.01
EBIT -- 92.38 56.31 5.69 -7.27
Net Profit 77.13 89.71 38.71 -7.57 -184.53
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsApr-26Apr-25Apr-24
EBIT-Margin info -206.58-206.58-206.58----
Net Margin info ---547.02------
Return on equity info -181.64-127.17-354.52-121.50-68.90
Return on Capital info -104.50-80.17-131.13-116.25-66.11
Return on Assets info -64.01-54.93-56.06-75.46-60.51
Debt to Equity (x) info -----55.910.070.04

Profitability

View Detailed Peer Comparison

ROCE

-131.13

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-131.13
-116.25
-66.11
-51.25
-36.08
Peer Median
--
--
--
--
--
ROE

-354.52

--

Profit after tax / Average Net worth * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-354.52
-121.50
-68.90
-53.69
-37.23
Peer Median
--
--
--
--
--
ROA

-56.06

--

Profit after tax / Average Total assets * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-56.06
-75.46
-60.51
-48.00
-34.60
Peer Median
--
--
--
--
--
EBIT Margin

-206.58

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-206.58
--
--
--
--
Peer Median
--
--
--
--
--
Net Margin

-223.16

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-223.16
--
--
-517.18
-576.85
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
--
--
--
--
-1.00
Peer Median
--
--
--
--
--
EBIT Growth

12.73

--

Year on year growth in operating profit (EBIT)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
12.73
-28.99
-42.08
-16.94
-40.38
Peer Median
--
--
--
--
--
Net Profit Growth

10.44

--

Year on year growth in profit after tax

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
10.44
-44.85
-36.31
-12.83
-78.05
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-55.91

--

Total debt / Net worth

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-55.91
0.07
0.04
0.05
0.04
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-0.60

--

(Short term borrowings / Net worth)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-0.60
0.02
0.01
0.01
0.01
Peer Median
--
--
--
--
--
Current Ratio

5.58

--

Current Assets / Current Liabilities and Provisions

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
5.58
5.35
9.90
11.46
16.73
Peer Median
--
--
--
--
--
Quick Ratio

5.52

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
5.52
5.35
9.90
--
16.49
Peer Median
--
--
--
--
--
Interest Coverage

-7.86

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-7.86
-30.12
--
-5.29
-74.60
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

15.35

--

Debtors outstanding / Net Sales * 100

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
15.35
--
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

0.25

--

Sales / Average Total Assets

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
0.25
--
--
--
--
Peer Median
--
--
--
--
--
Receivable days

65.60

--

Average Debtors / Sales * 365

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
65.60
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

103.05

--

Average Inventory / Sales * 365

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
103.05
--
--
1,233.74
1,331.71
Peer Median
--
--
--
--
--
Payable days

395.34

--

Average Creditors / Cost of goods sold * 365

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
395.34
2,715.12
29.51
1,925.30
1,381.12
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-226.69

--

Receivable Days + Inventory Days - Payable Days

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
-226.69
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

EV/EBITDA

0.99

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Apr-26
Apr-25
Apr-24
Apr-23
Apr-22
Kalvista Pharmaceuticals Inc (KALV)
0.99
1.05
1.51
1.50
1.96
Peer Median
--
--
--
--
--
loading...
loading...